Trial Profile
A randomized, double-blind, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Psychotic disorders
- Focus Therapeutic Use
- 26 Nov 2015 New trial record